Quest Diagnostics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell DGX and other ETFs, options, and stocks.

About DGX

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information, and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. 

CEO
James E. Davis
CEOJames E. Davis
Employees
57,000
Employees57,000
Headquarters
Secaucus, New Jersey
HeadquartersSecaucus, New Jersey
Founded
1967
Founded1967
Employees
57,000
Employees57,000

DGX Key Statistics

Market cap
26.22B
Market cap26.22B
Price-Earnings ratio
24.60
Price-Earnings ratio24.60
Dividend yield
1.43%
Dividend yield1.43%
Average volume
1.33M
Average volume1.33M
High today
$236.65
High today$236.65
Low today
$233.01
Low today$233.01
Open price
$235.96
Open price$235.96
Volume
654.99K
Volume654.99K
52 Week high
$240.13
52 Week high$240.13
52 Week low
$171.18
52 Week low$171.18

Stock Snapshot

Quest Diagnostics(DGX) stock is priced at $235.84, giving the company a market capitalization of 26.22B. It carries a P/E multiple of 24.60 and pays a dividend yield of 1.43%.

On 2026-08-06, Quest Diagnostics(DGX) stock traded between a low of $233.01 and a high of $236.65. Shares are currently priced at $235.84, which is +1.2% above the low and -0.3% below the high.

The Quest Diagnostics(DGX)'s current trading volume is 654.99K, compared to an average daily volume of 1.33M.

In the last year, Quest Diagnostics(DGX) shares hit a 52-week high of $240.13 and a 52-week low of $171.18.

In the last year, Quest Diagnostics(DGX) shares hit a 52-week high of $240.13 and a 52-week low of $171.18.

DGX News

Simply Wall St 38m
CVS Health Stock And Other Dividend Compounders For Higher Rates

The Federal Reserve has made it clear that inflation is still the main opponent, and that interest rates could rise again if price pressures do not ease from th...

CVS Health Stock And Other Dividend Compounders For Higher Rates
Simply Wall St 9h
Quest Diagnostics Lifts 2026 Outlook As Investors Ask If The Stock Is Fully Valued

Quest Diagnostics (DGX) stock has been in focus after the company reported second quarter and six month 2026 results and raised its full year revenue and earnin...

Quest Diagnostics Lifts 2026 Outlook As Investors Ask If The Stock Is Fully Valued

Analyst ratings

50%

of 20 ratings
Buy
45%
Hold
50%
Sell
5%

People also own

Based on the portfolios of people who own DGX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.